Regeneus Ltd (ASX:RGS) Japanese Patent Office to Grant Patent for Cancer Vaccine Technology

🕔2/12/2018 9:48:27 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine technology company, today announced that the Japanese Patent Office has issued a decision to grant a patent covering the use of cancer vaccine technology for the treatment of a range of cancers in humans and animals.

Read Full Article

Regeneus Ltd (ASX:RGS) Announces Successful Results in Acne Study

🕔2/6/2018 10:45:05 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that topical use of Sygenus gel for 6 weeks in adults with acne was well tolerated and showed a significant effect on the appearance of acne lesions as early as 3 weeks.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Achieves a Major US FDA Milestone in the Registration of Detach(R) with Approval of the Human Food Safety Dossier

🕔2/5/2018 8:29:16 AM

Anatara Lifesciences (ASX:ANR) has achieved a significant milestone in the United States of America after receiving a "complete" letter from the US Food and Drug Administration for the Technical Section of its Human Food Safety submission. The HFS is a major component of a New Animal Drug Application which is currently underway and is necessary for enabling the marketing of Detach(R) in the US.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report

🕔2/1/2018 8:27:51 AM

Queensland Bauxite Limited (ASX:QBL) provides the Company's Quarterly Activities Report.

Read Full Article

Nanollose Ltd (ASX:NC6) Quarterly Update

🕔1/31/2018 8:21:52 AM

Nanollose Limited (ASX:NC6) is pleased to provide its Appendix 4C Cashflow Statement for the quarter ended 31 December 2017, together with the following operational update.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives $1.23m R&D Tax Refund

🕔1/18/2018 9:38:13 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,230,329 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive scheme.

Read Full Article

Social Media

Fashion and Lifestyle